Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Forecast improvement within reach

Successful HFpEF therapy for the first time

    • Cardiology
    • Interviews
    • RX
    • Studies
  • 2 minute read

Prof. Stefan Anker, MD, provides a summary overview of the key outcomes of the EMPEROR-Preserved study.

Prof. Dr. med. Stefan Anker

Berlin-Brandenburg Center for Regenerative Therapies
Charité, University Medicine Berlin (D)

 

Can you give us a summary overview of the key outcomes of the EMPEROR-Preserved study?


Prof. Anker, MD:
This is the first success that can be recorded in the therapy of HFpEF. To put it in a nutshell: We are now seeing a success that has not happened for the last 18 years – despite five different attempts. It showed a really significant difference, which is also statistically significant – in a way that leaves no doubt. The 21% risk reduction is a difference that can not only be measured, but also felt. This is because patients’ symptoms and quality of life also improve. There are two aspects to quality of life: On the one hand, the quality of life measurable by questionnaires improved. But not having to spend part of your life in the hospital also promotes this significantly.

The positive results are predominantly due to the reduction in hospital stays. How should this fact be classified?

The study – and with it all other precursor studies as well – was designed to establish combined endpoints. So all-cause or cardiovascular mortality, as well as heart failure and hospitalization rates. The latter either as the first event or as the first and repeated events. The question then becomes how many hospitalizations happen and how quickly. This is because these are no longer included in the cardiovascular mortality endpoint. Now we are currently in a pandemic in which cardiovascular mortality has actually turned out to be a little higher than expected. Approximately one-third of all primary endpoints are cardiovascular deaths. The 21% identified corresponds to the combined endpoint. Looking at the individual components, while the reduction in cardiovascular mortality was 9%, heart failure hospitalization was more than 25% for both the first and repeat events, which was highly significant. This is relevant to patients because heart failure hospitalization affects prognosis. To see effects in mortality, the study may also not have been long enough, with a follow-up of 26 months. But aside from the resources needed for a longer study, it would also be unethical to continue such a study even though it has met the combined endpoint. Patients deserve to have this option for treatment.

The interview was conducted by Leoni Burggraf

 

 

CARDIOVASC 2021; 20(3): 38

Publikation
  • CARDIOVASC
Related Topics
  • HFpEF
Previous Article
  • Idiopathic pulmonary fibrosis

Change of therapy often useful

  • Congress Reports
  • Pneumology
  • RX
  • Studies
View Post
Next Article
  • Pelargonium sidoides

Enhanced antiviral effects through upregulation of the vitamin D receptor.

  • Education
  • General Internal Medicine
  • Infectiology
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 3 min
  • From symptom to diagnosis

Oncology – Thymoma

    • Cases
    • Education
    • Oncology
    • Radiology
    • RX
    • Surgery
View Post
  • 11 min
  • Shared decision making

Participatory decision-making using the example of diets for type 1 diabetes

    • CME continuing education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 12 min
  • Patient-centered rounds in medicine

Aligning care with the patient

    • CME continuing education
    • Education
    • General Internal Medicine
    • Prevention and health care
    • RX
    • Studies
View Post
  • 6 min
  • Migraine and vascular regulation

CGRP-targeted migraine therapies for vascular risk patients

    • Education
    • Neurology
    • RX
    • Studies
View Post
  • 6 min
  • Pediatric multiple sclerosis

Early high efficacy as the key to improving prognosis

    • Education
    • Genetics
    • Neurology
    • Pediatrics
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 6 min
  • Case report, molecular basis and therapeutic implications

HER2-positive colorectal carcinoma with invasive micropapillary component

    • Cases
    • Education
    • Gastroenterology and Hepatology
    • Oncology
    • RX
    • Studies
View Post
  • 7 min
  • Wound Care

Chronically infected wound on the lower leg – a case report

    • Cases
    • Congress Reports
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Geriatrics
    • Orthopedics
    • Prevention and health care
    • RX
    • Surgery
View Post
  • 5 min
  • From symptom to diagnosis

Dyspnea – thoracic lymphoma

    • Cases
    • Education
    • General Internal Medicine
    • Oncology
    • Pneumology
    • Radiology
    • RX
Top Partner Content
  • Herpes zoster

    Zum Thema
Top CME content
  • 1
    Aligning care with the patient
  • 2
    Participatory decision-making using the example of diets for type 1 diabetes
  • 3
    Colorectal cancer screening – an update
  • 4
    Yellow nail and Swyer-James syndrome
  • 5
    Individual therapy management for an optimized outcome – an update

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.